Table 3.

Responses of patients to immune checkpoint inhibitor therapy according to their GPS

	All patients (n = 80)	GPS: 0 (n = 42)	GPS: 1–2 (n = 38)
Complete response	1	1	0
Partial response	13	10	3
Stable disease	20	12	8
Progressive disease	42	17	25
Not evaluable	4	2	2
Response rate (95% CI)	17.5 (5.4–29.6)	26.2 (12.2–40.2)	7.9 (1.0–16.5)
			p = 0.03

 CI, confidence interval; GPS, Glasgow prognostic score.